The pharmacokinetics of eflornithine (α-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness

Author： Na-Bangchang K.   Doua F.   Konsil J.   Hanpitakpong W.   Kamanikom B.   Kuzoe F.  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.60, Iss.4, 2004-06, pp. : 269-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Say goodnight to African sleeping sickness with eflornithine

By  

Inpharma, Vol. 1, Iss. 1630-1631, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Development of eflornithine [difluoromethylornithine, DFMO] has been discontinued

By  

Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T

By Slanař Ondřej   Nobilis Milan   Kvétina Jaroslav   Matoušková Olga   Idle Jeffrey   Perlík František  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 4, 2007-04 ,pp. : 419-421

Springer Publishing Company

Access to resources Recommend Favorite

Development of drug-in-adhesive transdermal patch for α-asarone and in vivo pharmacokinetics and efficacy evaluation

By Hu Ying   Wu Yao-Yao   Xia Xiao-Jing   Wu Zheng   Liang Wen-Quan   Gao Jian-Qing  

Drug Delivery, Vol. 18, Iss. 1, 2011-01 ,pp. : 84-89

Informa Healthcare

Access to resources Recommend Favorite

Late-stage metastatic melanoma costs high

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 585, 2009-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite